> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Workshop on Developing Inhaled Antibacterial Drugs
- URL: https://www.fdaweb.com/fda-workshop-on-developing-inhaled-antibacterial-drugs/
- Published: 2018-06-08T12:00:00.000Z
- Updated: 2026-09-15T00:11:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141637

*Federal Register* notice: FDA has announced a 6/27 public workshop entitled “Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis.” The workshop is scheduled to discuss clinical trial design challenges and future considerations for inhaled antibacterial products to treat cystic fibrosis (CF) and non-CF bronchiectasis. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-06-08/pdf/2018-12341.pdf?ref=fdaweb.com).